Robert J. Beall Therapeutics Development Award

The Robert J. Beall Award, created in 2015, recognizes members of the CF scientific community whose work embodies and carries on Beall's innovative, determined and collaborative spirit in driving advances in CF research. 

2 min read

The Robert J. Beall Award, created in 2015, recognizes members of the CF scientific community whose work embodies and carries on Beall's innovative, determined and collaborative spirit in driving advances in CF research. 

During his 35 years with the Cystic Fibrosis Foundation -- 21 years as president and CEO -- Robert J. Beall, Ph.D., had a profound impact on the lives of people with CF. Under his leadership, the Foundation achieved unprecedented gains in research, treatment and care and significantly improved life expectancy for the disease. Beall pioneered the Foundation's successful venture philanthropy model, which has been a game changer in CF research and has led to the development of several breakthrough CF treatments, including the first drugs to address the underlying cause of the disease.   

The first recipients of the Robert J. Beall Award were the following:

  • Alan Verkman, M.D., Ph.D., professor of medicine and physiology at the University of California, San Francisco, School of Medicine
  • Luis Galietta, Ph.D., professor of molecular genetics at the University of Genoa, Italy

Drs. Verkman and Galietta were honored for their pioneering work to adapt high throughput screening methods to find compounds that could target the root cause of cystic fibrosis.

Research teams at Aurora Biosciences and Vertex Pharmaceuticals Inc. were also recognized for their significant contributions to bringing the first treatments that address the basic defect in CF into the hands of many of those living with the disease. 

Share this article
Topics
NACFC | North American CF Conference
Have questions? We’re here to help. Call us at 1-800-FIGHT CF

(1-800-344-4823)
Mon - Thu, 9 am - 7 pm ET
Fri, 9 am - 3 pm ET

 

More Ways To Get Help